{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:20Z","timestamp":1792478600045,"version":"4.5.0"},"reference-count":60,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15876","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:29Z","timestamp":1789990889000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of circulating tumour DNA in guiding postoperative adjuvant chemotherapy for resectable colorectal cancer: A meta\u2011analysis based on cohort studies"],"prefix":"10.3892","volume":"32","author":[{"given":"Jiale","family":"Ruan","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shi","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Shi","sequence":"additional","affiliation":[{"name":"Xiapu Subdistrict Community Health Service Center, Ningbo, Zhejiang 315700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Chen","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Feng","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xiangshan First People's Hospital Medical and Health Group, Ningbo, Zhejiang 315700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"key20261020093250_b1-ol-32-5-15876","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20261020093250_b2-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.annonc.2021.08.1752","article-title":"Pan-asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer","volume":"32","author":"Yoshino","year":"2021","journal-title":"Ann Oncol"},{"key":"key20261020093250_b3-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrclinonc.2016.199","article-title":"Surveillance after curative treatment for colorectal cancer","volume":"14","author":"Van Der Stok","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20261020093250_b4-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"key20261020093250_b5-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer","volume":"29","author":"Haller","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20261020093250_b6-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-Based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): Long-term results of a randomized controlled trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20261020093250_b7-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20261020093250_b8-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"key20261020093250_b9-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41571-023-00834-2","article-title":"Personalizing adjuvant therapy for patients with colorectal cancer","volume":"21","author":"Yang","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"key20261020093250_b10-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1758385","DOI":"10.3389\/fphys.2025.1758385","article-title":"A new paradigm in postoperative colorectal cancer surveillance: Integrating advanced imaging and multi-omics","volume":"16","author":"Yu","year":"2026","journal-title":"Front Physiol"},{"key":"key20261020093250_b11-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"e103910","DOI":"10.1371\/journal.pone.0103910","article-title":"A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"key20261020093250_b12-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cac2.12639","article-title":"The chinese society of clinical oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"key20261020093250_b13-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"key":"key20261020093250_b14-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in Stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"key":"key20261020093250_b15-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for Stage II colon cancer: ASCO guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20261020093250_b16-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.7150\/jca.104412","article-title":"Risk prediction of myelosuppression following First-line chemotherapy in colorectal cancer","volume":"16","author":"Du","year":"2025","journal-title":"J Cancer"},{"key":"key20261020093250_b17-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","article-title":"Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20261020093250_b18-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.4143\/crt.2023.1371","article-title":"Evaluation of molecular residual disease by a fixed panel in resectable colorectal cancer","volume":"56","author":"Yang","year":"2024","journal-title":"Cancer Res Treat"},{"key":"key20261020093250_b19-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"key20261020093250_b20-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells14030161","article-title":"Circulating tumor DNA testing for minimal residual disease and its application in colorectal cancer","volume":"14","author":"Abidoye","year":"2025","journal-title":"Cells"},{"key":"key20261020093250_b21-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-026-01126-1","article-title":"Evolving roles of liquid biopsy in precision medicine for colorectal cancer: From single-gene analysis to broad genomic profiling","volume":"23","author":"Martini","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"key":"key20261020093250_b22-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"key20261020093250_b23-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.1073\/pnas.1105422108","article-title":"Detection and quantification of rare mutations with massively parallel sequencing","volume":"108","author":"Kinde","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20261020093250_b24-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci Transl Med"},{"key":"key20261020093250_b25-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"key20261020093250_b26-ol-32-5-15876","article-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells","year":"2014"},{"key":"key20261020093250_b27-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key20261020093250_b28-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"17588359231220607","DOI":"10.1177\/17588359231220607","article-title":"Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I\u2013IV colorectal cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"key20261020093250_b29-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/cas.16442","article-title":"Impact of minimal residual disease on early recurrence of liver metastatic colorectal cancer","volume":"116","author":"Kawashima","year":"2025","journal-title":"Cancer Sci"},{"key":"key20261020093250_b30-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1097\/JS9.0000000000002504","article-title":"Dynamic CtDNA monitoring in adjuvant therapy and recurrence for colorectal liver metastases (PKUCRLM-01): A prospective study","volume":"111","author":"Xu","year":"2025","journal-title":"Int J Surg"},{"key":"key20261020093250_b31-ol-32-5-15876","first-page":"1","article-title":"Circulating tumor DNA status and adjuvant chemotherapy in resected colorectal liver metastases","author":"Kataoka","year":"2026","journal-title":"JAMA Oncol"},{"key":"key20261020093250_b32-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.annonc.2026.05.001","article-title":"Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO\/ABCSG trial","volume":"37","author":"Folprecht","year":"2026","journal-title":"Ann Oncol"},{"key":"key20261020093250_b33-ol-32-5-15876","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon","year":"1977","journal-title":"Cancer Res"},{"key":"key20261020093250_b34-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/JTO.0000000000000263","article-title":"Gefitinib treatment in EGFR mutated Caucasian NSCLC: Circulating-free tumor DNA as a surrogate for determination of EGFR status","volume":"9","author":"Douillard","year":"2014","journal-title":"J Thorac Oncol"},{"key":"key20261020093250_b35-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40291-021-00562-2","article-title":"Current and emerging applications of droplet digital PCR in oncology: An updated review","volume":"26","author":"Olmedillas-L\u00f3pez","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"key20261020093250_b36-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20261020093250_b37-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"oyaf204","DOI":"10.1093\/oncolo\/oyaf204","article-title":"Circulating tumor DNA detection in cancer: A comprehensive overview of current detection methods and prospects","volume":"30","author":"de Abreu","year":"2025","journal-title":"Oncologist"},{"key":"key20261020093250_b38-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0009-8981(01)00665-9","article-title":"About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA release","volume":"313","author":"Stroun","year":"2001","journal-title":"Clin Chim Acta"},{"key":"key20261020093250_b39-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ejso.2021.11.138","article-title":"Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage","volume":"48","author":"Kirchweger","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"key20261020093250_b40-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/1878-0261.13178","article-title":"Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1\/IKZF1","volume":"16","author":"Symonds","year":"2022","journal-title":"Mol Oncol"},{"key":"key20261020093250_b41-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"8820","DOI":"10.1002\/cam4.4384","article-title":"Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer","volume":"10","author":"Osumi","year":"2021","journal-title":"Cancer Med"},{"key":"key20261020093250_b42-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"BSR20180322","DOI":"10.1042\/BSR20180322","article-title":"Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients","volume":"38","author":"Yang","year":"2018","journal-title":"Biosci Rep"},{"key":"key20261020093250_b43-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"101883","DOI":"10.1016\/j.tranon.2024.101883","article-title":"Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment","volume":"42","author":"Egger","year":"2024","journal-title":"Transl Oncol"},{"key":"key20261020093250_b44-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"key20261020093250_b45-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"key":"key20261020093250_b46-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1245\/s10434-022-12728-1","article-title":"Circulating tumor DNA, imaging, and carcinoembryonic antigen: Comparison of surveillance strategies among patients who underwent resection of colorectal Cancer-A systematic review and Meta-analysis","volume":"30","author":"Dawood","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"key20261020093250_b47-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"e2300127","DOI":"10.1200\/PO.23.00127","article-title":"Tumor-Informed circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer","volume":"8","author":"Emiloju","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"key20261020093250_b48-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41571-020-0392-0","article-title":"ctDNA applications and integration in colorectal cancer: An NCI colon and Rectal-Anal task forces whitepaper","volume":"17","author":"Dasari","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"key20261020093250_b49-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of plasma Cell-Free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","volume":"5","author":"Reinert","year":"2019","journal-title":"JAMA Oncol"},{"key":"key20261020093250_b50-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/annonc\/mdz390","article-title":"Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer","volume":"30","author":"Tarazona","year":"2019","journal-title":"Ann Oncol"},{"key":"key20261020093250_b51-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","article-title":"Adjuvant chemotherapy for stage II colon cancer with poor prognostic features","volume":"29","author":"O'Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20261020093250_b52-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"key":"key20261020093250_b53-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","article-title":"Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: The randomized phase 2\/3 DYNAMIC-III trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"key":"key20261020093250_b54-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.annonc.2023.11.009","article-title":"Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer-evaluation in a nationwide Danish cohort","volume":"35","author":"Henriksen","year":"2024","journal-title":"Ann Oncol"},{"key":"key20261020093250_b55-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1073\/pnas.96.16.9236","article-title":"Digital PCR","volume":"96","author":"Vogelstein","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20261020093250_b56-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"e154941","DOI":"10.1172\/JCI154941","article-title":"Circulating tumor DNA: Current challenges for clinical utility","volume":"132","author":"Dang","year":"2022","journal-title":"J Clin Invest"},{"key":"key20261020093250_b57-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/bcr2431","article-title":"Next-generation sequencing","volume":"11","author":"Reis-Filho","year":"2009","journal-title":"Breast Cancer Res"},{"key":"key20261020093250_b58-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.mcp.2019.101480","article-title":"Technical progress in circulating tumor DNA analysis using next generation sequencing","volume":"49","author":"Bai","year":"2020","journal-title":"Mol Cell Probes"},{"key":"key20261020093250_b59-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-026-04428-0","article-title":"Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: A randomized phase 3 trial","volume":"32","author":"Bando","year":"2026","journal-title":"Nat Med"},{"key":"key20261020093250_b60-ol-32-5-15876","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-25-1242","article-title":"ctDNA longitudinal analysis during total neoadjuvant therapy and nonoperative management for locally advanced rectal cancer: A biomarker study from the NOMINATE Trial","volume":"31","author":"Akiyoshi","year":"2025","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:57Z","timestamp":1792477977000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15876","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}